IDO1-IN-13

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

IDO1-IN-13 

IDO1-IN-13 (compound 27a) 是一种有效的 IDO1 抑制剂，IC50 为 61.6 nM。IDO1-IN-13 具有细胞 IDO1 抑制作用 (HeLa EC50=30 nM)。在 SK-OV-3 异种移植肿瘤组织中，IDO1-IN-13 降低了 51% 的 kyn/trp 比率。

IDO1-IN-13

IDO1-IN-13 Chemical Structure

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

IDO1-IN-13 (compound 27a) is a potent IDO1 inhibitor with an IC50 of 61.6 nM. IDO1-IN-13 has cellular IDO1 inhibition (HeLa EC50= 30 nM). IDO1-IN-13 decreases 51% of the kyn/trp ratio in SK-OV-3 xenograft tumor tissues[1].

IC50 & Target[1]

IDO1

30 nM (IC50)

分子量

470.34

Formula

C20H16BrN5O2S
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Yeh TK, et al. Discovery and development of a novel N-(3-bromophenyl)-{[(phenylcarbamoyl)amino]methyl}-N-hydroxythiophene-2-carboximidamide indoleamine 2,3-dioxygenase inhibitor using knowledge-based drug design. Eur J Med Chem. 2022;229:114043.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务